Metformin use and hospital attendance‐related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based cohort study

Metformin use and hospital attendance‐related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based cohort study

Abstract Background Androgen deprivation therapy (ADT), used increasingly in the treatment of prostate cancer (PCa), negatively influences glycemic control in diabetes and is associated with an increased risk of diabetes complications where hospitalization commonly ensues. Metformin could decrease t...

Full description

Bibliographic Details
Main Authors: Yan Hiu Athena Lee, Jeremy Man Ho Hui, Cheuk To Chung, Kang Liu, Edward Christopher Dee, Kenrick Ng, Gary Tse, Jeffrey Shi Kai Chan, Chi Fai Ng
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Medicine
Subjects:
androgen deprivation therapy
diabetes
medical costs
metformin
prostate cancer
Online Access:https://doi.org/10.1002/cam4.5651

Internet

https://doi.org/10.1002/cam4.5651

Similar Items